ArticlePharmaceutics2022

Design, Synthesis and In Vitro Investigation of Cabozantinib-Based PROTACs to Target c-Met Kinase.

Anastasia A Sachkova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.